Foundation Medicine (FMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -22,393 | -17,037 |
| Depreciation Amortization | 2,894 | 1,520 |
| Accounts receivable | -1,917 | 973 |
| Accounts payable and accrued liabilities | 147 | -338 |
| Other Working Capital | 480 | 99 |
| Other Operating Activity | 3,540 | 650 |
| Operating Cash Flow | $-17,249 | $-14,133 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -3,183 | -5,410 |
| Investing Cash Flow | $-3,183 | $-5,410 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | N/A | 2,974 |
| Common Stock Issued | 70 | 114 |
| Other Financing Activity | 64,348 | 25,898 |
| Financing Cash Flow | $64,418 | $28,986 |
| Beginning Cash Position | 10,852 | 1,409 |
| End Cash Position | 54,838 | 10,852 |
| Net Cash Flow | $43,986 | $9,443 |
| Free Cash Flow | ||
| Operating Cash Flow | -17,249 | -14,133 |
| Capital Expenditure | -3,183 | -5,410 |
| Free Cash Flow | -20,432 | -19,543 |